F946-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[1-(3,5-dimethyl-1,2-oxazol-4-yl)-6-oxo-1,6-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide

F946-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[1-(3,5-dimethyl-1,2-oxazol-4-yl)-6-oxo-1,6-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide
F946-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[1-(3,5-dimethyl-1,2-oxazol-4-yl)-6-oxo-1,6-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F946-0151
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[1-(3,5-dimethyl-1,2-oxazol-4-yl)-6-oxo-1,6-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F946-0151

Molecular Formula

C24H22N4O6S (C24 H22 N4 O6 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[1-(3,5-dimethyl-1,2-oxazol-4-yl)-6-oxo-1,6-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-5-[1-(35-dimethyl-12-oxazol-4-yl)-6-oxo-16-dihydropyridazin-3-yl]-2-methylbenzene-1-sulfonamide

SMILES

Cc1noc(C)c1N(C(C=C1)=O)N=C1c1cc(S(Nc(cc2)cc3c2OCCO3)(=O)=O)c(C)cc1

InChI

InChI=1S/C24H22N4O6S/c1-14-4-5-17(19-7-9-23(29)28(25-19)24-15(2)26-34-16(24)3)12-22(14)35(30,31)27-18-6-8-20-21(13-18)33-11-10-32-20/h4-9,12-13,27H,10-11H2,1-3H3

InChI Key

PZYFVAHHLDBWDK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27205485

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.53

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.615

Distribution Coefficient, logD

1.921

Water Solubility, LogSw

-3.05

Polar Surface Area

105.037

Acid Dissociation Constant (pKa)

6.80

Base Dissociation Constant (pKb)

1.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

F946-0151 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antifungal Library (16415 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Agro:
  • Agro
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F946-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F946-0151?
Check Price and Availability of F946-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F946-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F946-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F946-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F946-0151 available by request